Edition:
India

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

70.80USD
14 Dec 2017
Change (% chg)

$-0.82 (-1.14%)
Prev Close
$71.62
Open
$71.63
Day's High
$71.87
Day's Low
$70.47
Volume
1,747,769
Avg. Vol
1,737,437
52-wk High
$84.55
52-wk Low
$66.46

Chart for

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $78,194.16
Shares Outstanding(Mil.): 1,016.57
Dividend: 0.50
Yield (%): 2.60

Financials

  Industry Sector
P/E (TTM): -- 21.41 16.44
EPS (TTM): -- -- --
ROI: -- 11.88 10.62
ROE: -- 13.57 14.20

CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

08 Dec 2017

CVS expects Justice Department to handle review of Aetna deal

WASHINGTON CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

08 Dec 2017

UPDATE 1-CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON, Dec 7 CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

08 Dec 2017

CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON, Dec 7 U.S. drugstore chain operator CVS Health Corp expects the Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman said.

08 Dec 2017

BRIEF-Egalet Says Notified Verbally By CVS Caremark That Sprix Will No Longer Be On Formulary For A Portion Of Commercial Covered Lives Beginning 2018

* EGALET - NOTIFIED VERBALLY BY CVS CAREMARK THAT SPRIX WILL NO LONGER BE ON FORMULARY FOR A PORTION OF COMMERCIAL COVERED LIVES BEGINNING JAN 1, 2018

07 Dec 2017

BRIEF-CVS Health Says ‍CVS Pharmacy Launches Free, Same-Day Prescription Delivery In Manhattan​

* SAYS ‍CVS PHARMACY LAUNCHES FREE, SAME-DAY PRESCRIPTION DELIVERY IN MANHATTAN​

06 Dec 2017

PRESS DIGEST - Wall Street Journal - Dec 6

Dec 6 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

06 Dec 2017

CVS likely wants FTC antitrust review, not Justice Department, of Aetna deal

WASHINGTON It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc , but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say. | Video

06 Dec 2017

BRIEF-CVS Says Co Would Be Required To Pay To Aetna Termination Fee Of $2.1 Bln If Merger Agreement Is Terminated

* CVS HEALTH CORP SAYS CO WOULD BE REQUIRED TO PAY TO AETNA A TERMINATION FEE OF $2.1 BILLION IF THE MERGER AGREEMENT IS TERMINATED - SEC FILING

06 Dec 2017

CVS likely wants FTC antitrust review, not Justice Dept, of Aetna deal

WASHINGTON, Dec 5 It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc, but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say.

05 Dec 2017

Earnings vs. Estimates